Brief: Dermata Therapeutics Had $10.6 Mln In Cash As Of June 30, 2022
Aug 15 (Reuters) - Dermata Therapeutics Inc DRMA.O :
* DERMATA THERAPEUTICS INC - AS OF JUNE 30, 2022, DERMATA
HAD
$10.6 MILLION IN CASH, COMPARED TO $10.8 MILLION AS OF DECEMBER
31, 2021
* DERMATA THERAPEUTICS INC - EXISTING CASH EQUIVALENTS
EXPECTED TO
FUND OPERATIONS INTO THE THIRD QUARTER OF 2023
* DERMATA THERAPEUTICS INC - QTRLY NET LOSS PER COMMON
SHARE,
BASIC AND DILUTED $0.24
Source text for Eikon: [https://bit.ly/3SKEIGa]
Further company coverage: DRMA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dermata Therapeutics
See all newsNASDAQ RESUMED AT 10:31 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:26 AM
Brief: Dermata Therapeutics - To Launch First Commercial Product Tome Foundational Treatment On August 25, 2026
Dermata Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Dermata Therapeutics Inc expected to post a loss of 55 cents a share - Earnings Preview